From these observations, the hyperactivation of the WNK-SPAK/OSR1-NCC pathway is gaining attention as one of the main molecular mechanisms underlying hypertension in PHAII patients1, 9, 10. This evidence concerns the gene STK39 and pseudohypoaldosteronism type 2.